Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell proliferation and advancement of hepatocarcinogenesis in the rat are associated with a decrease in connexin 32

H Tsuda1, M Asamoto, H Baba

  • 1Chemotherapy Division, National Cancer Center Research Institute, Tokyo, Japan.

Carcinogenesis
|January 1, 1995
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effectiveness of preemptive analgesia varies according to the type of surgery: a randomized, double-blind study.

Anesthesia and analgesia·1999
Same author

HLA genotyping of 5,000- and 6,000-year-old ancient bones in Japan.

Tissue antigens·1999
Same author

Paraganglioma of the cauda equina: MR findings.

Radiation medicine·1999
Same author

Thymidine phosphorylase activity and angiogenesis in gastric cancer.

Oncology reports·1999
Same author

Potential usefulness of 18F-2-fluoro-deoxy-D-glucose positron emission tomography in cervical compressive myelopathy.

Spine·1999
Same author

Recapping T-saw laminoplasty for spinal cord tumors.

Spine·1999

Connexin 32 (Cx32) expression decreases significantly during liver regeneration and hepatocarcinogenesis in rats. This reduction correlates with increased cell proliferation and altered enzyme expression, indicating cellular independence and growth advantage in liver cancer progression.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Cancer Research

Background:

  • Connexin 32 (Cx32) is a key gap junction protein in hepatocytes.
  • Understanding Cx32's role in liver regeneration and cancer is crucial for therapeutic development.

Purpose of the Study:

  • To investigate Cx32 expression changes after partial hepatectomy (PH) in rats.
  • To analyze Cx32 levels during hepatocarcinogenesis, from preneoplastic lesions to hepatocellular carcinoma (HCC).
  • To correlate Cx32 expression with cell proliferation and altered enzyme expression.

Main Methods:

  • Quantitative immunohistochemistry was used to measure Cx32 protein spots on hepatocyte membranes.
  • Livers were analyzed sequentially after PH and during chemically induced carcinogenesis (N-ethyl-N-hydroxyethylnitrosamine).

Related Experiment Videos

  • Cell proliferation was assessed using 5-bromo-2'-deoxyuridine (BrdU) labeling indices.

    • Main Results:

    • Cx32 expression rapidly decreased after PH, reaching lowest levels during the S phase of cell proliferation.
    • A progressive decline in Cx32 was observed from enzyme-altered foci (EAF) to hyperplastic nodules (HN) and HCC.
    • Pulmonary metastatic and transplanted HCC showed zero Cx32 expression.
    • Inverse correlations were found between Cx32 levels, BrdU index, and altered enzyme expression in HN.

    Conclusions:

    • Cx32 downregulation is closely linked to hepatocyte proliferation and the progression of liver cancer.
    • Decreased Cx32 expression may signify increased cellular independence and growth advantage, contributing to hepatocarcinogenesis.
    • Cx32 levels can serve as a biomarker for assessing the proximity of preneoplastic lesions to HCC.